Pristane induced changes in rat lymphocyte membrane fluidity
- PMID: 2383857
Pristane induced changes in rat lymphocyte membrane fluidity
Abstract
The ability of pristane (2,6,10,14-tetramethylpentadecane) to act as a membrane perturbant was examined. Data obtained from rats treated with pristane by either intraperitoneal injection or the diet indicated there were significant increases over normal in the amount of pristane in lymphoid cells; 50-89% was incorporated into the plasma membranes. Fluorescence polarization analyses, using 1,6-diphenyl-1,3,5-hexatriene, of normal plasma membrane isolates demonstrated that splenic and Peyer's patch lymphocytic membranes were more viscous than those of the thymus, mesenteric lymph nodes or peripheral blood. Studies to assess the effects of pristane on membrane viscosity demonstrated that there were significant differences in the viscosities of plasma membrane isolates from lymphocytes of normal versus pristane treated rats. The observed changes were dependent on route of administration, length of exposure and the lymphoid organ examined.
Similar articles
-
The fluidity of DOPC bilayers and membrane fractions prepared from murine plasmacytoma cells is unchanged after incorporation of pristane (2,6,10,14-tetramethylpentadecane) as assessed by fluorescence polarization analysis.Cancer Biochem Biophys. 1992 Nov;13(2):85-92. Cancer Biochem Biophys. 1992. PMID: 1343851
-
Pristane induced effects on chromatin of rat lymphoid cells.J Cell Biochem. 1991 Mar;45(3):311-6. doi: 10.1002/jcb.240450314. J Cell Biochem. 1991. PMID: 2066383
-
Cholesterol modulation of membrane fluidity and ecto-nucleotide triphosphatase activity in human normal and CLL lymphocytes.Anticancer Res. 1987 May-Jun;7(3 Pt B):347-52. Anticancer Res. 1987. PMID: 2957950
-
Changes in the DNA of lymphocytes from pristane treated rats.Agents Actions. 1987 Feb;20(1-2):104-12. doi: 10.1007/BF01965632. Agents Actions. 1987. PMID: 3577955
-
Translocation and activation of protein kinase C by the plasma cell tumor-promoting alkane pristane.Cancer Res. 1995 Feb 1;55(3):518-24. Cancer Res. 1995. PMID: 7834620
Cited by
-
Pristane-induced lupus: considerations on this experimental model.Clin Rheumatol. 2017 Nov;36(11):2403-2414. doi: 10.1007/s10067-017-3811-6. Epub 2017 Sep 6. Clin Rheumatol. 2017. PMID: 28879482 Review.
-
The tumor promoter pristane activates transcription by a cAMP dependent mechanism.Mol Cell Biochem. 1992 Mar 4;110(1):75-81. doi: 10.1007/BF02385008. Mol Cell Biochem. 1992. PMID: 1315928
-
Induction of autoimmunity by pristane and other naturally occurring hydrocarbons.Trends Immunol. 2009 Sep;30(9):455-64. doi: 10.1016/j.it.2009.06.003. Epub 2009 Aug 19. Trends Immunol. 2009. PMID: 19699150 Free PMC article. Review.
-
The arthritogenic adjuvant squalene does not accumulate in joints, but gives rise to pathogenic cells in both draining and non-draining lymph nodes.Clin Exp Immunol. 2002 Mar;127(3):430-5. doi: 10.1046/j.1365-2249.2002.01783.x. Clin Exp Immunol. 2002. PMID: 11966758 Free PMC article.
-
Influence of hydrocarbon oil structure on adjuvanticity and autoimmunity.Sci Rep. 2017 Nov 8;7(1):14998. doi: 10.1038/s41598-017-15096-z. Sci Rep. 2017. PMID: 29118363 Free PMC article.